Immunovant, Inc. (IMVT)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 28.32 |
| Open | 28.27 |
| Bid | 28.20 x 100 |
| Ask | 28.30 x 100 |
| Day's Range | 27.33 - 28.64 |
| 52 Week Range | 15.39 - 45.58 |
| Volume | |
| Avg. Volume | 1,159,373 |
| Market Cap | 4.1B |
| Beta (5Y Monthly) | 0.70 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.81 |
| Earnings Date | May 13, 2024 - May 27, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 50.86 |
ZacksWhat Makes Immunovant (IMVT) a New Buy Stock
Immunovant (IMVT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Investor's Business DailyArgenx, Immunovant Soar — As Tourmaline Plummets — On A Rival's Lackluster Test Results
Biotech stocks Argenx and Immunovant surged Thursday — and Tourmaline fell — on a rival's lackluster muscle disease drug study.
Insider Monkey11 Oversold Biotech Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold biotech stocks to buy right now. To skip our detailed analysis of the biotech sector, you can go directly to see the 5 Oversold Biotech Stocks To Buy Right Now. Dealmaking in Biotech Healthcare has been performing well so far in 2024, and […]
© 2024 Yahoo. All rights reserved.